鉴定DUSP4/6过度表达作为NRAS诱导的肝癌发生的潜在静态
Sophie Klemm1, Katja Evert1, Kirsten Utpatel1
1Institute of Pathology, University of Regensburg, Regensburg, Germany.
BMC cancer
|November 10, 2023
概括
神经母细胞瘤RAS病毒性瘤基因同源 (NRAS) 突变可以在小鼠中启动肝癌. 过度表达的双特异性酸酶4和6 (DUSP4/6) 和CD133可能是肝细胞癌的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 线素激活蛋白激酶 (MAPK) 途径失调在肝细胞癌 (HCC) 中很常见.
- 神经母细胞瘤RAS病毒瘤基因同类 (NRAS) 突变在HCC的一个子集中发现,但以前没有被认为是肝癌的足够驱动因素.
- 这项研究调查了NRAS驱动的肝癌发生,并确定了潜在的治疗点.
研究的目的:
- 描述NRAS依赖性肝癌发生的过程.
- 确定NRAS驱动的HCC中的分子漏洞和潜在的治疗点.
主要方法:
- NRAS V12等离子体通过水力动态尾静脉注射 (HTVI) 引入小鼠肝脏.
- 使用NanoString®基因表达,西部斑块和免疫组织化学 (IHC) 分析了瘤和前瘤组织.
- 使用HCC细胞系的体外研究证实了基因表达的变化.
主要成果:
- NRAS V12表达诱导了与小鼠肝脏中HCC相似的新生和新生病变.
- 观察到RAS/RAF/MEK/ERK信号通路的升级.
- 在病变中检测到癌症干细胞标记物CD133和双特异性酸酶4和6 (DUSP4/6) 的过度表达.
- 在体外,NRAS V12增加了DUSP4/6的表达,这具有悖论的降低了化ERK (pERK),而当沉默时,增加了HCC细胞的增殖.
结论:
- G12V NRAS突变足以在小鼠中驱动肝癌发生,挑战了以前的假设.
- MAPK通路激活与增加的DUSP4,DUSP6和CD133表达相关.
- DUSP4和DUSP6可能充当MAPK信号传递的负调节者,为HCC提供潜在的治疗点.
更多相关视频
08:52Live Imaging of Innate Immune and Preneoplastic Cell Interactions Using an Inducible Gal4/UAS Expression System in Larval Zebrafish Skin
Published on: February 3, 2015
12.1K
10:31The Drosophila Imaginal Disc Tumor Model: Visualization and Quantification of Gene Expression and Tumor Invasiveness Using Genetic Mosaics
Published on: October 6, 2016
11.2K
相关概念视频
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
MAPK Signaling Cascades
5.6K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
